| JPMorgan Chase & Co. | Institution | 21.028.373 | 8,90% | 79,07M € | 2026-05-18 |
| Artal Group S.A. | Institution | 15.945.067 | 6,75% | 59,95M € | 2025-11-13 |
| Invus Public Equities, L.P. | Institution | 15.945.067 | 6,75% | 59,95M € | 2025-11-13 |
| Biodiscovery 6 FPCI | Institution | 14.114.476 | 5,97% | 53,07M € | 2025-12-31 |
| Andera Partners | Institution | 14.114.476 | 5,97% | 53,07M € | 2026-03-31 |
| Samsara BioCapital LLC | Institution | 13.540.194 | 5,73% | 50,91M € | 2026-03-31 |
| Sofinnova Crossover I | Institution | 12.332.804 | 5,22% | 46,37M € | 2025-12-31 |
| Eventide Healthcare Innovation Fund I LP | Institution | 9.368.517 | 3,97% | 35,23M € | 2025-12-31 |
| Eventide Asset Management, LLC | Institution | 9.368.517 | 3,97% | 35,23M € | 2026-03-31 |
| BVF Partners L.P. | Institution | 8.545.499 | 3,62% | 32,13M € | 2026-03-31 |
| Sofinnova Partners SAS | Institution | 8.433.227 | 3,57% | 31,71M € | 2026-06-02 |
| Samsara Biocapital, L.P. | Institution | 8.345.389 | 3,53% | 31,38M € | 2025-11-17 |
| Deep Track Biotechnology Master Fund, Ltd | Institution | 7.800.465 | 3,30% | 29,33M € | 2026-03-31 |
| Deep Track Capital, LP | Institution | 7.800.465 | 3,30% | 29,33M € | 2026-03-31 |
| Perceptive Advisors LLC | Institution | 6.945.995 | 2,94% | 26,12M € | 2025-09-30 |
| Perceptive Life Sciences Master Fund, Ltd. | Institution | 6.945.995 | 2,94% | 26,12M € | 2025-09-30 |
| Sofinnova Crossover Ii S.L.P. | Institution | 6.753.246 | 2,86% | 25,39M € | 2025-12-31 |
| New Enterprise Associates, Inc. | Institution | 6.684.064 | 2,83% | 25,13M € | 2026-03-31 |
| New Enterprise Associates 17, L.P. | Institution | 6.684.064 | 2,83% | 25,13M € | 2026-03-30 |
| Mr. Frederic Cren | Insider | 5.878.991 | 2,49% | 22,11M € | 2026-03-04 |
| Samsara Opportunity Fund, L.P. | Institution | 5.194.805 | 2,20% | 19,53M € | 2025-11-17 |
| Qatar Holding LLC | Institution | 5.157.233 | 2,18% | 19,39M € | 2025-07-22 |
| Caligan Partners, LP | Institution | 4.974.906 | 2,11% | 18,71M € | 2026-03-31 |
| Polar Capital Holdings Plc | Institution | 4.632.138 | 1,96% | 17,42M € | 2026-03-31 |
| Biotechnology Value Fund L.P. | Institution | 4.630.461 | 1,96% | 17,41M € | 2025-11-17 |
| Paradigm Biocapital Advisors LP | Institution | 4.000.000 | 1,69% | 15,04M € | 2026-03-31 |
| Biomedical Value Fund | Institution | 3.658.944 | 1,55% | 13,76M € | 2025-09-30 |
| Great Point Partners, LLC | Institution | 3.449.937 | 1,46% | 12,97M € | 2025-12-31 |
| Dr. Pierre Broqua | Insider | 3.428.070 | 1,45% | 12,89M € | 2026-03-04 |
| Biotechnology Value Fund II, L.P. | Institution | 3.321.861 | 1,41% | 12,49M € | 2025-11-17 |
| Millennium Management LLC | Institution | 2.987.613 | 1,26% | 11,23M € | 2026-03-31 |
| Trails Edge Capital Partners, LP | Institution | 2.657.997 | 1,12% | 9,99M € | 2026-03-31 |
| Franklin Resources, Inc. | Institution | 2.461.565 | 1,04% | 9,26M € | 2026-03-31 |
| Symbiosis Capital Partners, LLC | Institution | 2.354.000 | 1,00% | 8,85M € | 2026-03-31 |
| UBS Asset Management AG | Institution | 2.318.693 | 0,98% | 8,72M € | 2026-03-31 |
| Ally Bridge Group | Institution | 2.245.300 | 0,95% | 8,44M € | 2026-03-31 |
| ADAR1 Capital Management, LLC | Institution | 2.174.398 | 0,92% | 8,18M € | 2026-03-31 |
| The Goldman Sachs Group, Inc. | Institution | 1.932.160 | 0,82% | 7,26M € | 2026-03-31 |
| NEA 18 Venture Growth Equity, L.P. | Institution | 1.666.666 | 0,71% | 6,27M € | 2026-03-30 |
| Biomedical Offshore Value Fund, LTD. | Institution | 1.643.874 | 0,70% | 6,18M € | 2025-09-30 |
| Boothbay Fund Management, LLC | Institution | 1.470.407 | 0,62% | 5,53M € | 2026-03-31 |
| Ikarian Capital, LLC | Institution | 1.429.101 | 0,60% | 5,37M € | 2026-03-31 |
| Inventiva S.A. Esop | Institution | 1.338.127 | 0,57% | 5,03M € | 2024-10-15 |
| Nextbio Capital Management Lp | Institution | 1.333.484 | 0,56% | 5,01M € | 2026-03-31 |
| RTW Investments, LP | Institution | 1.298.702 | 0,55% | 4,88M € | 2026-03-31 |
| Artisan Partners Limited Partnership | Institution | 960.865 | 0,41% | 3,61M € | 2026-03-31 |
| Point72 Asset Management, L.P. | Institution | 956.221 | 0,40% | 3,60M € | 2026-03-31 |